imipramine has been researched along with Paralysis, Sleep in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Side effects were common and almost half these patients became tolerant, needing higher dosage to control symptoms." | 1.25 | Natural history, symptoms and treatment of the narcoleptic syndrome. ( Asselman, P; Baraitser, M; Marsden, CD; Parkes, JD, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parkes, JD | 1 |
| Baraitser, M | 1 |
| Marsden, CD | 1 |
| Asselman, P | 1 |
1 other study available for imipramine and Paralysis, Sleep
| Article | Year |
|---|---|
Natural history, symptoms and treatment of the narcoleptic syndrome.
Topics: Adult; Aged; Antidepressive Agents, Tricyclic; Cataplexy; Central Nervous System Stimulants; Clomipr | 1975 |